Brittni Kalyuzhny
Family · Staten Island, NYNPI 1538684360
Payments from drug & device makers
Across 121 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$362
- Almirall LLC$243
- LEO Pharma Inc.$240
- Johnson & Johnson$232
- Sanofi$187
- Incyte Corporation$166
- plus $1K from 19 others
Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Almirall LLC$1K
What the payments were for
- Food & beverage$2,599100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 18 | $362 |
| Almirall LLC | 11 | $243 |
| LEO Pharma Inc. | 12 | $240 |
| Johnson & Johnson | 8 | $232 |
| Sanofi | 7 | $187 |
| Incyte Corporation | 7 | $166 |
| Lilly USA, LLC | 9 | $164 |
| Dermavant Sciences, Inc. | 7 | $147 |
| Novartis | 5 | $130 |
| AbbVie | 6 | $106 |
| Regeneron Healthcare Solutions, Inc. | 3 | $100 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $87 |
| Amgen | 4 | $78 |
| Arcutis Biotherapeutics, Inc. | 4 | $64 |
| E.r. Squibb & Sons, L.L.C. | 2 | $47 |
| Convatec Inc. | 2 | $44 |
| EPI Health, LLC | 2 | $42 |
| Galderma Laboratories, L.p. | 2 | $30 |
| Strata Skin Sciences, Inc. | 2 | $24 |
| UCB, Inc. | 1 | $23 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $23 |
| Organon | 1 | $20 |
| Pfizer | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Mission Pharmacal Company | 1 | $11 |
How this compares
$2,599 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 109 | $2,070 |
| Tacrolimus | 11 | $950 |
| Gentamicin Sulfate | 23 | $855 |
| Triamcinolone Acetonide | 90 | $824 |
| Clobetasol Propionate | 15 | $780 |
| Fluocinolone Acetonide | 15 | $662 |
| Ciclopirox | 20 | $615 |
| CiclopiroxCiclopirox Olamine | 14 | $152 |
| Mupirocin | 12 | $121 |
| Hydrocortisone | 16 | $106 |
Paid to pharmacies, not to this prescriber.
Other family in Staten Island
- John de OcaStaten Island$86K
- Daniel OstrowskiStaten Island$25K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.